Company Number: 13678878

Analysis Date: 2025-07-29 14:18 UTC

Financial Health Assessment of THE FINAL VIEW LIMITED

---

1. Financial Health Score: C

Explanation:
THE FINAL VIEW LIMITED shows mixed financial vital signs. While the company remains solvent with positive net assets, recent indicators reveal signs of financial strain, particularly a sharp reduction in working capital and cash reserves. The score reflects a company that is still operational but exhibiting symptoms of liquidity stress that require management attention.

---

2. Key Vital Signs

Metric	2023 (Latest)	2022 (Prior Year)	Interpretation
Current Assets	£40,685	£37,268	Slight increase, but composition changed drastically (cash down, debtors up).
Cash at Bank	£8,809	£31,268	Significant drop (~72%), indicating reduced liquid funds — a vital sign of cash flow stress.
Trade Debtors	£0	£6,000	Decline in trade debtors, offset by an increase in other debtors, possibly related-party or prepayments.
Current Liabilities	£36,659	-£24,367	Shift from net creditor to net debtor position; current liabilities increased sharply.
Net Current Assets (Working Capital)	£4,026	£61,635	Drastic reduction in working capital, symptom of potential cash flow problems.
Net Assets (Equity)	£9,274	£61,635	Significant erosion of equity, signaling accumulated losses or withdrawals.
Shareholders' Funds	£9,274	£61,635	Mirrors net assets; equity base has shrunk substantially.
Employees	2	2	Stable, but very small workforce, typical for a micro/small consultancy.
Loans from Directors	-£94,446	-£72,323	Increased director loans reflect reliance on internal financing, which can be a liquidity lifeline but also a risk if not sustainable.

---

3. Diagnosis

• Symptoms of Distress:
  The company's cash reserves have shrunk markedly, from £31k to under £9k, indicating a drying up of immediately available funds. Concurrently, current liabilities have surged from a net creditor position to a net debtor position of ~£37k, exerting pressure on liquidity. This squeeze in working capital is a classic symptom of cash flow distress, potentially caused by increased payables, taxes, or social security liabilities that outpace collections or cash inflows.

• Erosion of Equity Base:
  The net assets have dropped from over £61k to just over £9k within roughly one year. This signals accumulated losses or distributions without replenishment, weakening the financial buffer and reducing the company's ability to absorb shocks.

• Reliance on Director Loans:
  The company has increased loans from directors to nearly £95k, which can be viewed as an internal bailout mechanism. While this can provide short-term liquidity, it may also increase financial risk if external funding or operational cash flow does not improve.

• Asset Investments:
  The acquisition of tangible fixed assets (~£5,756) is noted, which while an investment in operational capacity, could further strain liquidity if not matched by revenue growth.

• Accounting and Reporting:
  The company benefits from audit exemption under the small companies regime, with accounts prepared under FRS 102 Section 1A. The absence of an audit means external validation of financial health is limited, placing greater emphasis on internal controls and management vigilance.

• Business Activity:
  Operating in management consultancy (SIC 70229), the company likely depends heavily on human capital and receivables. Its small employee base and high reliance on director loans suggest it is still in a developmental or turnaround phase.

---

4. Recommendations

1. Enhance Cash Flow Management:

• Prioritize collection of receivables and optimize payment terms with creditors to improve liquidity.
• Consider detailed cash flow forecasting to anticipate and mitigate short-term cash shortages.

2. Address Working Capital Deficit:

• Review current liabilities to negotiate extended payment terms or restructure obligations if possible.
• Monitor VAT and tax liabilities closely to avoid penalties or enforcement actions.

3. Equity Strengthening:

• Explore options for fresh equity injection or capital contributions to rebuild the financial buffer and reduce reliance on director loans.

4. Operational Efficiency:

• Assess asset utilization to ensure fixed asset investments are justified by revenue growth.
• Maintain tight control over expenses, especially given small scale and limited resources.

5. Financial Reporting and Governance:

• Although audit exemption applies, consider voluntary external review to enhance stakeholder confidence.
• Strengthen financial controls and reporting timeliness to detect and respond to financial issues promptly.

---

Medical Analogy Summary

THE FINAL VIEW LIMITED's financial "pulse" is weak: a sharp drop in "cash flow oxygen" and a "working capital heartbeat" that has thinned dangerously. The company's "immune system"—its equity—has been eroded, making it vulnerable to external shocks. Immediate "treatment" focusing on liquidity restoration and capital strengthening is essential to prevent progression towards financial "collapse."

---